BRIEF-pSivida says Alimera to resubmit marketing approval application for Iluvien to FDA by end March

March 22 (Reuters) - pSivida Corp :

* Reports updates on Iluvien for planned resubmission to FDA and European

launch

* Says Alimera announced it intends to resubmit its NDA for Iluvien for DME to

FDA by end of March 2013 * Source text * Further company coverage

((Bangalore Newsroom; +1 646 223 8780))

View the original article here